Evidence map›Paper›PMID 22987294›Full record

Trial reportInternational journal of hematology2012

Role of CD61+ cells in thrombocytopenia of dengue patients.

Sansanee Noisakran, Nattawat Onlamoon, Kovit Pattanapanyasat, Hui-Mien Hsiao, Pucharee Songprakhon, Nasikarn Angkasekwinai, Kulkanya Chokephaibulkit, Francois Villinger, Aftab A Ansari, Guey Chuen Perng

Abstract readClinical Trial
In one paragraph

Trial report in International journal of hematology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 33 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Thrombocytopenia in Virus Infections.Journal of clinical medicine · 2021
    Review
  5. Article
  6. Review
  7. Article
  8. Dengue type 1 viruses circulating in humans are highly infectious and poorly neutralized by human antibodies.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Sansanee NoisakranDepartment of Pathology and Laboratory Medicine, Emory Vaccine Center, Emory University School of Medicine, Dental School Building, Room 429, 1462 Clifton Road, Atlanta, GA 30322, USA.
Nattawat Onlamoon
Kovit Pattanapanyasat
Hui-Mien Hsiao
Pucharee Songprakhon
Nasikarn Angkasekwinai
Kulkanya Chokephaibulkit
Francois Villinger
Aftab A Ansari
Guey Chuen Perng
Emory University · USMahidol University · THSiriraj Hospital · TH

Funding

YNPRC NHP CLINICAL MEDICINE RESIDENCY PROGRAM - SUPPLEMENTP51RR000165 · NCRR · EMORY UNIVERSITY · PI ALTMAN, JOHN DAVID · 1985 to 2011
$114.0M
VACCINE INDUCED IMMUNITY IN THE YOUNG AND AGEDU19AI057266 · NIAID · EMORY UNIVERSITY · PI Rafi Ahmed · 2003 to 2026
$81.7M
Resource for Nonhuman Primate Immune ReagentsR24OD010947 · OD · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI VILLINGER, FRANCOIS J · 2012 to 2025
$4.9M
NCRR NIH HHS P51 RR000165NIAID NIH HHS RFA-AI-02-042NIAID NIH HHS U19 AI057266NIH HHS R24 OD010947
6 · The paper itself

Abstract

Although hematological disorders with salient features of thrombocytopenia have been well documented in dengue patients, the role of CD61-expressing platelets and the megakaryocytic cell lineage in the pathogenesis of dengue virus (DENV) infection remains largely unexplored. A prospective observational study was performed using blood samples and PBMCs from dengue-confirmed patients, as well as from rhesus monkeys (RM) experimentally infected with DENV. Immunohistochemical staining and FACS techniques were applied to evaluate the frequencies of CD61(+) cells that contained DENV antigen. Highly enriched population of CD61(+) cells was also isolated from acute DENV-infected RM and assayed for DENV RNA by quantitative RT-PCR. Results revealed that DENV antigen was found in small vesicles of varying size, and more frequently in anucleated cells associated with platelets in dengue patients. The DENV antigen-containing cells were CD61(+) and appeared to share characteristics of megakaryocytes. Kinetic profiles of CD61(+) cells from DENV-infected RM revealed a transient increase in CD61(+)CD62P(+) cells early after DENV infection. DENV RNA in a highly enriched population of CD61(+) cells from the infected RM was observed during acute stage. Our results indicate that virus containing CD61(+) cells may be directly linked to the platelet dysfunction and low platelet count characteristics of dengue patients.

Indexed as

Blood PlateletsDengueMegakaryocytesThrombocytopeniaAcute DiseaseAnimalsAntigens, ViralDengue VirusFemaleHumansIntegrin beta3Macaca mulattaMaleProspective StudiesRNA, ViralAntigens, ViralIntegrin beta3ITGB3 protein, humanRNA, Viral

Identifiers

PMID22987294
PMCPMC3606877
OpenAlexW1973020193

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.